Captor Therapeutics Spolka Akcyjna Future Growth
Future criteria checks 2/6
Captor Therapeutics Spolka Akcyjna is forecast to grow revenue at 22.3% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 34.7% |
| Revenue growth rate | 22.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 13 Jun 2024 |
Recent future growth updates
Recent updates
Here's Why We're Not Too Worried About Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn Situation
Jul 13
We Think Captor Therapeutics Spolka Akcyjna (WSE:CTX) Can Afford To Drive Business Growth
Mar 10We're Not Worried About Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn
Oct 03Here's Why We're Not At All Concerned With Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn Situation
Mar 13Companies Like Captor Therapeutics Spolka Akcyjna (WSE:CTX) Can Afford To Invest In Growth
Jun 15Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 78 | N/A | 6 | 20 | 1 |
| 12/31/2025 | 54 | N/A | -24 | -9 | 1 |
| 12/31/2024 | 12 | N/A | -52 | -41 | 1 |
| 3/31/2024 | 16 | -66 | -58 | -55 | N/A |
| 12/31/2023 | 13 | -71 | -55 | -52 | N/A |
| 9/30/2023 | 13 | -66 | -40 | -37 | N/A |
| 6/30/2023 | 11 | -58 | -43 | -41 | N/A |
| 3/31/2023 | 10 | -39 | -26 | -25 | N/A |
| 12/31/2022 | 9 | -36 | -24 | -23 | N/A |
| 9/30/2022 | 5 | -40 | -32 | -26 | N/A |
| 6/30/2022 | 5 | -41 | -32 | -27 | N/A |
| 3/31/2022 | 5 | -38 | -29 | -24 | N/A |
| 12/31/2021 | 4 | -33 | -34 | -28 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if CTX's forecast earnings growth is above the savings rate (3.9%).
Earnings vs Market: Insufficient data to determine if CTX's earnings are forecast to grow faster than the Polish market
High Growth Earnings: Insufficient data to determine if CTX's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: CTX's revenue (22.3% per year) is forecast to grow faster than the Polish market (4.4% per year).
High Growth Revenue: CTX's revenue (22.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CTX's Return on Equity is forecast to be high in 3 years time